Executive Wealth Management LLC Takes $394,000 Position in Aflac Incorporated (NYSE:AFL)

Executive Wealth Management LLC acquired a new position in Aflac Incorporated (NYSE:AFL) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 3,520 shares of the financial services provider’s stock, valued at approximately $394,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of AFL. Y.D. More Investments Ltd acquired a new stake in shares of Aflac in the 2nd quarter worth $25,000. Catalyst Capital Advisors LLC purchased a new stake in shares of Aflac during the third quarter worth about $51,000. Valued Wealth Advisors LLC increased its holdings in shares of Aflac by 116.7% during the third quarter. Valued Wealth Advisors LLC now owns 479 shares of the financial services provider’s stock valued at $54,000 after acquiring an additional 258 shares in the last quarter. Fairscale Capital LLC purchased a new position in shares of Aflac in the 2nd quarter valued at approximately $54,000. Finally, Cedar Wealth Management LLC acquired a new stake in Aflac in the 1st quarter worth approximately $50,000. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Aflac Stock Up 0.8 %

Aflac stock opened at $108.29 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.08 and a quick ratio of 0.10. The stock has a market capitalization of $60.16 billion, a PE ratio of 16.31, a price-to-earnings-growth ratio of 2.06 and a beta of 0.96. The business has a 50 day simple moving average of $110.33 and a 200-day simple moving average of $98.56. Aflac Incorporated has a 12 month low of $75.07 and a 12 month high of $115.50.

Aflac (NYSE:AFL) last issued its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, topping the consensus estimate of $1.69 by $0.47. The company had revenue of $2.95 billion during the quarter, compared to analyst estimates of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The firm’s revenue was down 40.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.84 EPS. On average, analysts anticipate that Aflac Incorporated will post 7.05 EPS for the current fiscal year.

Aflac Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Wednesday, November 20th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.85%. The ex-dividend date is Wednesday, November 20th. Aflac’s dividend payout ratio is presently 30.12%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Citigroup lifted their price objective on shares of Aflac from $84.00 to $93.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 23rd. Bank of America boosted their price target on Aflac from $115.00 to $124.00 and gave the company a “buy” rating in a research note on Thursday, October 10th. Wells Fargo & Company increased their price objective on Aflac from $106.00 to $107.00 and gave the company an “equal weight” rating in a report on Tuesday. Piper Sandler lifted their target price on Aflac from $114.00 to $122.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Finally, Barclays began coverage on shares of Aflac in a report on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 price target on the stock. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $97.93.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.